Made in USA Pharma Supply Chain Amendment Passes Unanimously
Sen. Tina Smith’s bill to provide $500 million in grants for domestic pharmaceutical manufacturers passes with flying colors and will be part of PREVENT Pandemics Act.
House Hearing on FDA: Advanced Manufacturing May – or May Not – Lead to Domestic Manufacturing Boom
The House Committee on Energy and Commerce discussed FDA’s user fee budget and what can be done to reshore more of the pharmaceutical industry.
CPA Letter to House Leadership Regarding Procuring “Made in China” Masks
CPA sent the following letter to House Speaker Nancy Pelosi (D-CA) and Minority Leader Kevin McCarthy (R-CA) regarding the Office of the Attending Physician’s distribution
Covid Supply Chain Crunch: Asian-Made PPE Stuck at Ports, Supplies Late
Recent supply chain bottlenecks of hospital gear shows why continued dependence on Asia is bad for pandemic preparedness. The Make PPE in America Act in the infrastructure law should remedy this in the years ahead, if Congress doesn’t open the doors to duty-free PPE and undercut the law’s intent.
Global Pharma Supply Chain Survey Shows Free Trade Not The Solution
Free trade loses out to a bigger government role in securing domestic supply chains of critical medication.
CPA Applauds Brown, Baldwin Letter to USTR Tai Urging Support of U.S. PPE Production & to End Tariff Exclusions on Chinese PPE
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded U.S. Senators Sherrod Brown (D-OH) and Tammy Baldwin (D-WI) for leading a letter to
Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman
CPA’s report, titled “Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman,” details how a loophole
New CPA Report Documents How Hatch-Waxman Act Loophole Led to Offshoring of Generics Production, Price Gouging, and Shortages
WASHINGTON — The Coalition for a Prosperous America (CPA) today released a new academic report that details how a loophole in the Hatch-Waxman Act has
‘Made in America’ Pandemic Preparedness Act Passes Committee Unanimously. Now What?
Both houses of Congress have bills that have passed committees, easily, in regard to building domestic supply of personal protective equipment for medical staff. These bills need to hit the floor so President Biden can sign them. But, more importantly, Buy American provisions face serious WTO risk, making all of this action moot.
Making The Case For Reshoring Critical Drugs, Where 90% Of Inputs Are In China’s Hands
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
